日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Correction: Optimising Paediatric HIV Treatment: Recent Developments and Future Directions

更正:优化儿童艾滋病治疗:最新进展与未来方向

Kamphuis, Anne E M; Bamford, Alasdair; Tagarro, Alfredo; Cressey, Tim R; Bekker, Adrie; Amuge, Pauline; Mujuru, Hilda Angela; Ndongo, Francis Ateba; Diack, Aminata; Compagnucci, Alexandra; Lallemant, Marc; Colbers, Angela; Turkova, Anna

Simultaneous pharmacokinetic modeling of unbound and total darunavir with ritonavir in adolescents: a substudy of the SMILE trial

青少年中游离达芦那韦和总达芦那韦与利托那韦的同步药代动力学建模:SMILE试验的子研究

Abdalla, Seef; Compagnucci, Alexandra; Riault, Yoann; Chan, Man K; Bamford, Alasdair; Nolan, Aoife; Ramos, José T; Constant, Valentin; Nguyen, Thao-Nguyen; Zheng, Yi; Tréluyer, Jean-Marc; Froelicher-Bournaud, Léo; Neveux, Nathalie; Saidi, Yacine; Cressey, Tim R; Hirt, Déborah

Optimising Paediatric HIV Treatment: Recent Developments and Future Directions

优化儿童艾滋病治疗:最新进展与未来方向

Kamphuis, Anne E M; Bamford, Alasdair; Tagarro, Alfredo; Cressey, Tim R; Bekker, Adrie; Amuge, Pauline; Mujuru, Hilda Angela; Ndongo, Francis Ateba; Diack, Aminata; Compagnucci, Alexandra; Lallemant, Marc; Colbers, Angela; Turkova, Anna

Nucleoside/nucleotide reverse transcriptase inhibitor sparing regimen with once daily integrase inhibitor plus boosted darunavir is non-inferior to standard of care in virologically-suppressed children and adolescents living with HIV - Week 48 results of the randomised SMILE Penta-17-ANRS 152 clinical trial

在病毒学抑制的 HIV 感染儿童和青少年中,每日一次整合酶抑制剂联合达芦那韦增强治疗方案(无需使用核苷/核苷酸类逆转录酶抑制剂)不劣于标准治疗方案——随机 SMILE Penta-17-ANRS 152 临床试验第 48 周结果

Compagnucci, Alexandra; Chan, Man K; Saïdi, Yacine; Cressey, Tim R; Bamford, Alasdair; Riault, Yoann; Coelho, Alexandra; Nolan, Aoife; Chalermpantmetagul, Suwalai; Morkunaite, Gabija; Amuge, Pauline; Musiime, Victor; Violari, Avy; Cotton, Mark; Kekitiinwa, Adeodata R; Kaudha, Elizabeth; Groenewald, Marisa; Liberty, Afaaf A; Kanjanavanit, Suparat; Volokha, Alla; Bologna, Rosa; Pavia Ruz, Noris; Prieto Tato, Luis; Paioni, Paolo; Marques, Laura; Reliquet, Véronique; Niehues, Tim; Welch, Steven B; Ford, Deborah; Giaquinto, Carlo; Gibb, Diana M; Babiker, Abdel; Ramos Amador, Jose Tomas

Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children

多替拉韦作为儿童 HIV-1 感染的一线或二线治疗方案

Turkova, Anna; White, Ellen; Mujuru, Hilda A; Kekitiinwa, Adeodata R; Kityo, Cissy M; Violari, Avy; Lugemwa, Abbas; Cressey, Tim R; Musoke, Philippa; Variava, Ebrahim; Cotton, Mark F; Archary, Moherndran; Puthanakit, Thanyawee; Behuhuma, Osee; Kobbe, Robin; Welch, Steven B; Bwakura-Dangarembizi, Mutsa; Amuge, Pauline; Kaudha, Elizabeth; Barlow-Mosha, Linda; Makumbi, Shafic; Ramsagar, Nastassja; Ngampiyaskul, Chaiwat; Musoro, Godfrey; Atwine, Lorna; Liberty, Afaaf; Musiime, Victor; Bbuye, Dickson; Ahimbisibwe, Grace M; Chalermpantmetagul, Suwalai; Ali, Shabinah; Sarfati, Tatiana; Wynne, Ben; Shakeshaft, Clare; Colbers, Angela; Klein, Nigel; Bernays, Sarah; Saïdi, Yacine; Coelho, Alexandra; Grossele, Tiziana; Compagnucci, Alexandra; Giaquinto, Carlo; Rojo, Pablo; Ford, Deborah; Gibb, Diana M

ODYSSEY clinical trial design: a randomised global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested pharmacokinetic sub-studies to evaluate pragmatic WHO-weight-band based dolutegravir dosing

ODYSSEY 临床试验设计:一项随机全球研究,旨在评估基于多替拉韦的抗逆转录病毒疗法在 HIV 阳性儿童中的疗效和安全性,并嵌套药代动力学亚研究,以评估基于 WHO 体重分级的实用性多替拉韦给药方案。

Moore, Cecilia L; Turkova, Anna; Mujuru, Hilda; Kekitiinwa, Adeodata; Lugemwa, Abbas; Kityo, Cissy M; Barlow-Mosha, Linda N; Cressey, Tim R; Violari, Avy; Variava, Ebrahim; Cotton, Mark F; Archary, Moherndran; Compagnucci, Alexandra; Puthanakit, Thanyawee; Behuhuma, Osee; Saϊdi, Yacine; Hakim, James; Amuge, Pauline; Atwine, Lorna; Musiime, Victor; Burger, David M; Shakeshaft, Clare; Giaquinto, Carlo; Rojo, Pablo; Gibb, Diana M; Ford, Deborah

Weekends-off efavirenz-based antiretroviral therapy in HIV-infected children, adolescents and young adults (BREATHER): Extended follow-up results of a randomised, open-label, non-inferiority trial

在 HIV 感染的儿童、青少年和年轻成人中,周末停用依非韦伦类抗逆转录病毒疗法(BREATHER):一项随机、开放标签、非劣效性试验的扩展随访结果

Turkova, Anna; Moore, Cecilia L; Butler, Karina; Compagnucci, Alexandra; Saïdi, Yacine; Musiime, Victor; Nanduudu, Annet; Kaudha, Elizabeth; Cressey, Tim R; Chalermpantmetagul, Suwalai; Scott, Karen; Harper, Lynda; Montero, Samuel; Riault, Yoann; Bunupuradah, Torsak; Volokha, Alla; Flynn, Patricia M; Bologna, Rosa; Ramos Amador, Jose T; Welch, Steven B; Nastouli, Eleni; Klein, Nigel; Giaquinto, Carlo; Ford, Deborah; Babiker, Abdel; Gibb, Diana M

Hepatic, Renal, Hematologic, and Inflammatory Markers in HIV-Infected Children on Long-term Suppressive Antiretroviral Therapy.

接受长期抑制性抗逆转录病毒治疗的 HIV 感染儿童的肝脏、肾脏、血液和炎症标志物

Melvin Ann J, Warshaw Meredith, Compagnucci Alexandra, Saidi Yacine, Harrison Linda, Turkova Anna, Tudor-Williams Gareth

HIV-1 Drug Resistance and Second-Line Treatment in Children Randomized to Switch at Low Versus Higher RNA Thresholds

儿童HIV-1耐药性和二线治疗:低RNA阈值与高RNA阈值随机切换治疗方案

Harrison, Linda; Melvin, Ann; Fiscus, Susan; Saidi, Yacine; Nastouli, Eleni; Harper, Lynda; Compagnucci, Alexandra; Babiker, Abdel; McKinney, Ross; Gibb, Diana; Tudor-Williams, Gareth

Adherence to antiretroviral therapy and acceptability of planned treatment interruptions in HIV-infected children

HIV感染儿童对抗逆转录病毒疗法的依从性和对计划性治疗中断的接受度

Harrison, Linda; Ananworanich, Jintanat; Hamadache, Djamel; Compagnucci, Alexandra; Penazzato, Martina; Bunupuradah, Torsak; Mazza, Antonio; Ramos, Jose Tomas; Flynn, Jacquie; Rampon, Osvalda; Mellado Pena, Maria Jose; Floret, Daniel; Marczynska, Magdalena; Puga, Ana; Forcat, Silvia; Riault, Yoann; Lallemant, Marc; Castro, Hannah; Gibb, Diana M; Giaquinto, Carlo